Clinical Trial Update: Epigenetic Reprogramming of Monocytes in Patients With Coronary Atherosclerosis

View source ↗

Summary

A completed clinical trial evaluated epigenetic reprogramming of monocytes in patients with atherosclerosis. The sponsor is Radboud University Medical Center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Snippet

Sponsor: Radboud University Medical Center | Conditions: Atherosclerosis | Status: COMPLETED